EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC-ND 4.0

From pathogenesis to precision medicine: Transformative advances in research and treatment of ameloblastoma

Zhang Zhao, Gan Xiong, Cheng Wang, Wei Cao

Cancer Letters · 2025-03 · 612 · 217448

DOI: 10.1016/j.canlet.2025.217448 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Cancer Letters, 2025-03. Verfasst von Zhang Zhao und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Oral and Maxillofacial & Head and Neck Oncology, Shanghai Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine, Sh…. Hauptthemen laut MEDLINE: Ameloblastoma, Precision Medicine, Jaw Neoplasms. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 153 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: National Natural Science Foundation of China, High-level Hospital Construction Project of Guangdong Provincial People's Hospital.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Odontogenic neoplasms of the jaw are dominated by ameloblastoma (AM), a locally aggressive epithelial tumor with a significant propensity for recurrence. The World Health Organization's 2022 update to the AM classification system underscores recent progress in comprehending its underlying mechanisms and refining clinical approaches. Contemporary research has yielded significant insights into the genetic underpinnings of AM, paving the way for the development of precision-based treatment strategies. Advanced genetic profiling has revealed a significant frequency of BRAF (V-raf murine sarcoma viral oncogene homolog) V600E and SMO (Smoothened) gene alterations in AM. Importantly, therapeutic interventions specifically designed to target these genetic aberrations, including BRAF and MEK pathway blockers, have shown encouraging results in terms of both effectiveness and tolerability, as documented in individual case reports and small-scale clinical investigations. This comprehensive review summarizes the recent modifications to the World Health Organization's categorization of AMs, explores progress in elucidating their underlying molecular pathways, and evaluates emerging targeted treatment modalities. Our objective is to present a thorough synthesis of contemporary scientific discoveries and therapeutic interventions, potentially paving the way for more efficacious and individualized clinical management protocols for this complex neoplasm.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AmeloblastomaPrecision MedicineJaw NeoplasmsHumansProto-Oncogene Proteins B-rafMolecular Targeted TherapyAnimals

Stichwörter der Autor:innen

AmeloblastomaBRAF V600ESMOTargeted therapyWHO classification

Substanzen

Proto-Oncogene Proteins B-rafBRAF protein, human

Autor:innen und Institutionen

  • Department of Oral and Maxillofacial & Head and Neck Oncology, Shanghai Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China; National Center for Stomatology, National Clinical Rese…
  • Hospital of Stomatology, Sun Yat-sen University, Guangzhou, China; Guangdong Provincial Key Laboratory of Stomatology, Sun Yat-sen University, Guangzhou, China; Guanghua School of Stomatology, Sun Yat-sen University, Gu…

Förderung

  • National Natural Science Foundation of China
  • High-level Hospital Construction Project of Guangdong Provincial People's Hospital

Zitieren

APA

Zhao, Z., Xiong, G., Wang, C., & Cao, W. (2025). From pathogenesis to precision medicine: Transformative advances in research and treatment of ameloblastoma. Cancer Letters, 612, 217448. https://doi.org/10.1016/j.canlet.2025.217448

Vancouver

Zhao Z, Xiong G, Wang C, Cao W. From pathogenesis to precision medicine: Transformative advances in research and treatment of ameloblastoma. Cancer Letters. 2025;612:217448. doi:10.1016/j.canlet.2025.217448

BibTeX
@article{Zhao2025,
  author = {Zhao, Zhang and Xiong, Gan and Wang, Cheng and Cao, Wei},
  title = {From pathogenesis to precision medicine: Transformative advances in research and treatment of ameloblastoma},
  journal = {Cancer Letters},
  year = {2025},
  volume = {612},
  pages = {217448},
  doi = {10.1016/j.canlet.2025.217448}
}
Kostenlos starten →